Cedar Hill Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-3,331
| Closed | -$269K | – | 152 |
|
|
2017
Q3 | $269K | Buy |
+3,331
| New | +$269K | 0.05% | 131 |
|
|
2016
Q2 | – | Sell |
-35,783
| Closed | -$3.29M | – | 76 |
|
|
2016
Q1 | $3.29M | Buy |
35,783
+930
| +3% | +$85.4K | 0.57% | 49 |
|
|
2015
Q4 | $3.53M | Sell |
34,853
-820
| -2% | -$83K | 0.62% | 49 |
|
|
2015
Q3 | $3.5M | Sell |
35,673
-32,563
| -48% | -$3.2M | 0.62% | 48 |
|
|
2015
Q2 | $7.99M | Sell |
68,236
-1,000
| -1% | -$117K | 1.26% | 37 |
|
|
2015
Q1 | $6.79M | Buy |
69,236
+2,335
| +3% | +$229K | 1.08% | 46 |
|
|
2014
Q4 | $6.31M | Buy |
66,901
+2,686
| +4% | +$253K | 1% | 49 |
|
|
2014
Q3 | $6.84M | Sell |
64,215
-2,839
| -4% | -$302K | 1.11% | 46 |
|
|
2014
Q2 | $5.56M | Sell |
67,054
-52,325
| -44% | -$4.34M | 0.88% | 49 |
|
|
2014
Q1 | $8.46M | Sell |
119,379
-6,475
| -5% | -$459K | 1.42% | 36 |
|
|
2013
Q4 | $9.45M | Sell |
125,854
-1,252
| -1% | -$94K | 1.68% | 24 |
|
|
2013
Q3 | $7.99M | Sell |
127,106
-6,277
| -5% | -$395K | 1.52% | 31 |
|
|
2013
Q2 | $6.84M | Buy |
+133,383
| New | +$6.84M | 1.34% | 31 |
|